METISOX
Contact us

Webinars · Open to everyone

Sharing what we've learned

For more than 20 years, our toxicologists, molecular biologists and bioinformaticians have been curating evidence on targets, mechanisms and safety. Along the way, we've built a deep understanding of how safety questions are actually answered in drug discovery and development.

We think that knowledge should not stay inside client reports. That's why we regularly host open webinars for anyone working in the pharmaceutical industry and related fields.

Open to everyone

You don't need to be a Metisox client. Toxicologists, safety scientists, translational researchers, BD teams and students are all welcome.

Free to attend

No fees and no sales pitch. Just science and a conversation.

Grounded in real work

Our sessions draw on 1,000+ target assessments and real regulatory and due diligence questions, so you leave with ideas you can apply.

From Complexity to Clarity: Leveraging Target Safety Assessment to Combat Drug Attrition — 5 November 2026, 17:00 CET

Upcoming

From Complexity to Clarity: Leveraging Target Safety Assessment to Combat Drug Attrition

Safety remains one of the leading causes of drug attrition, and many of these risks can be identified long before a candidate reaches the clinic. In this session, we'll show how a structured target safety assessment turns scattered evidence into a clear picture of risk, so teams can make earlier, better-informed decisions and avoid costly late-stage failures.

5 November 2026 · 17:00 CET · Free, open to everyone

Register

Webinar series

Webinars on demand

RNA-seq data analysisTarget Safety AssessmentCarcinogenicity Risk AssessmentSysWiz

Our recent topics

Missed a session? Watch the recordings of our recent webinars.

Never miss a session

Want to hear about our next webinar? Follow us on LinkedIn or write to info@metisox.com and we'll add you to the invitation list.

Have a topic you'd like us to cover? Let us know. Many of our sessions start with a question from the community.

Follow on LinkedInEmail us

Posters at SOT2022

Other materials

Bioinformatics approach in reducing cancer drug attrition

Bioinformatics approach in reducing cancer drug attrition

How to get the most out of your RNA-seq data. Precision insights is your answer

How to get the most out of your RNA-seq data. Precision insights is your answer

Is electronic cigarette inhalation toxic for healthy never smokers. Bioinformatics reveals the answer

Is electronic cigarette inhalation toxic for healthy never smokers. Bioinformatics reveals the answer